Family · Pharmaceutical analytical standards
Tamoxifen
A selective oestrogen receptor modulator (SERM), synthesised in England in 1962 by chemist Dora Richardson: first marketed in the UK in 1973, it is a cornerstone of breast cancer treatment. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?It was born in a project for a contraceptive pill, but early studies showed it stimulated ovulation instead of suppressing it. In 1998 it became the first FDA-approved medicine to reduce the risk of breast cancer.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
